| Bid Price | 210.00p | High Price | 221.00p |
|---|
| Ask Price | 220.00p | Low Price | 210.00p |
|---|
| Open Price | 216.00p | Spread | 4.55% |
|---|
| Prev Close | 216.00p | Volume | 2,920 |
|---|
Faron Pharmaceuticals Oy Historic Prices
| Date | Open | High | Low | Close | Volume |
|---|
| Sep 20, 2024 | 216.00 | 221.00 | 210.00 | 215.00 | 2,920 |
| Sep 19, 2024 | 224.00 | 228.00 | 213.00 | 216.00 | 7,785 |
| Sep 18, 2024 | 227.00 | 229.91 | 220.00 | 224.00 | 10,827 |
| Sep 17, 2024 | 227.00 | 228.75 | 224.00 | 227.00 | 16,909 |
| Sep 16, 2024 | 221.00 | 227.00 | 212.00 | 227.00 | 9,205 |
Faron Pharmaceuticals Oy Information
| Name | Faron Pharmaceuticals Oy | Index | FTSE AIM All Share |
|---|
| ISIN | FI4000153309 | Epic | FARN |
|---|
| Type | Equity | Currency | GBX |
|---|
| Record Status | Active | Trading Segment | ASQ1 |
|---|
| Industry | Biotechnology | Sector | Healthcare |
|---|
| EMS | 750 | Trading Status | Closed |
|---|
| Shares in Issue | 104.62 m | Prev Close | 216.00p |
|---|
| PE Ratio | | Market Cap | £224.94 m |
|---|
| Div Yield | 0 | Div per Share | €NaN |
|---|
| EPS | -€0.20 | Div Cover | NaN |
|---|
| PEG | n/a | EPS Growth (%) | 0.00 |
|---|
| ROCE | n/a | DPS Growth (%) | 0 |
|---|
| Current Ratio | 1.445792 | Quick Ratio | 1.445792 |
|---|
Faron Pharmaceuticals Oy Director Deals
| Declared | Type | Director | Pos. | Volume / Price | Value |
|---|
| 24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Markku Jalkanen | CEO | 16,667 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Yrjo Wichmann | RES | 2,333 @ £0.00 | £0.00 |
| 24/06/24 | TIN | Tuomo Patsi | NED | 6,667 @ £0.00 | £0.00 |
| 24/06/24 | PLAC | Christine Roth | NED | 46,075 @ €1.00 | €46,075.00 |
| 09/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 09/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 09/04/24 | PLAC | Tuomo Patsi | NED | 13,333 @ £1.50 | £20,000.00 |
| 04/04/24 | BUY | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
| 04/04/24 | PLAC | Markku Jalkanen | CEO | 33,333 @ £1.50 | £50,000.00 |
Faron Pharmaceuticals Oy News
